Shane Thomas Gleason Net Worth

What's Shane Gleason's mailing address?

Shane's mailing address filed with the SEC is C/O INSPIREMD, INC., 4 MENORAT HAMAOR ST., TEL AVIV, L3, 6744832.

Insiders trading at InspireMD Inc

Over the last 13 years, insiders at InspireMD Inc have traded over $1,684,082 worth of InspireMD Inc stock and bought 3,887,125 units worth $5,293,286 . The most active insiders traders include Sol J Barer, Eli Bar et Gary S Roubin. On average, InspireMD Inc executives and independent directors trade stock every 97 days with the average trade being worth of $319,459. The most recent stock trade was executed by Gary S Roubin on 30 November 2023, trading 50,000 units of NSPR stock currently worth $126,500.

What does InspireMD Inc do?

inspiremd, inc. is a company based out of 800 boylston street suite 16041, boston, massachusetts, united states.

InspireMD Inc executives and stock owners

InspireMD Inc executives and other stock owners filed with the SEC include:

• Marvin L. Slosman,
  Pres, CEO & Director
• Craig Shore,
  CFO, Chief Admin. Officer, Sec. & Treasurer
• Craig Shore,
  Chief Financial Officer, Chief Administrative Officer, Treasurer and Secretary
• Campbell Rogers,
  Independent Director
• Michael Berman,
  Independent Director
• Gary Roubin,
  Director
• Thomas Kester,
  Director
• Agustin Gago,
  Executive Vice President, Chief Commercial Officer
• Isaac Blech,
  Independent Vice Chairman of the Board
• Marvin Slosman,
  Chief Executive Officer, Director
• Paul Stuka,
  Chairman of the Board
• Dr. Sol J. Barer Ph.D.,
  Special Advisor to the Board
• Amir Kohen,
  VP of Fin. & International HR
• Andrea Tommasoli,
  Sr. VP of Global Sales & Marketing
• Roei Samuri,
  VP of Operations
• Sol J Barer,
  Director
• James J Barry,
  President and CEO
• James J Loughlin,
  Director
• Alan Milinazzo,
  President and CEO
• Eric L. Olson,
  VP of Global Sales Operations
• Eli Bar,
  CTO InspireMD Ltd.
• Asher Holzer,
  Director
• Eyal Weinstein,
  Director
• Kathryn Arnold,
  Director
• Shane Thomas Gleason,
  Chief Commercial Officer
• Patrick Verta,
  EVP Clinical/Medical Affairs